Editorial: A Time of Transition of Alzheimer's Disease in the Advent of Anti-Amyloid Monoclonal Antibodies

Neurol Ther. 2021 Dec;10(2):409-413. doi: 10.1007/s40120-021-00286-9. Epub 2021 Oct 13.

Authors

Babak Tousi¹, Marwan Noel Sabbagh²

Affiliations

¹ Cleveland Clinic Center for Brain Health, Cleveland, OH, USA.
² Cleveland Clinic Lou Ruvo Center for Brain Health, 888 W. Bonneville Ave, Las Vegas, NV, 89106, USA. marwan.sabbagh@dignityhealth.org.

No abstract available

Keywords: Aducanumab; Alzheimer’s disease; Disease-modifying treatments; Mild cognitive impairment; Monoclonal antibodies.

Publication types

Editorial

Grants and funding